The Pharmacokinetics Study of Fotagliptin in Patients with Different Degrees of Renal Insufficiency

Clinical trial NCT06883656 · COMPLETED

Trial details

NCT number: NCT06883656
Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus (T2DM)Renal Insuficiency

Start date: 2022-03-15
Primary completion: 2022-11-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.